Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Decapeptyl SR 6-monthly vs 3-monthly in advanced prostate cancer
NCT01673984Phase 4Terminated
- Sponsor
- Ipsen
- Start
- Aug 2012
- Primary completion
- Feb 2014
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of triptorelin in prostate cancer (PCa), sponsored by Ipsen. Started Aug 2012; status: terminated.
02
Drugs
triptorelin
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT01673984.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01673984.